Rationale and design of the multicentric, double-blind, double-placebo, randomized trial APrepitant versus HYdroxyzine in association with cytoreductive treatments for patients with myeloproliferative neoplasia suffering from Persistent Aquagenic Pruritus. Trial acronym: APHYPAP.

Item request has been placed!

Item request cannot be made.

Processing Request

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

المؤلفون: Le Gall-Ianotto, C.^1,2 (AUTHOR) ; Verdet, R.³ (AUTHOR); Nowak, E.³ (AUTHOR); Le Roux, L.⁴ (AUTHOR); Gasse, A.⁴ (AUTHOR); Fiedler, A.^5,6 (AUTHOR); Carlhant-Kowalski, D.⁷ (AUTHOR); Marcorelles, P.^2,8,9 (AUTHOR); Misery, L.^1,2 (AUTHOR); Ianotto, J. C.^10,11 (AUTHOR)
المصدر:
Trials. 12/19/2021, Vol. 22 Issue 1, p1-15. 15p. 1 Color Photograph, 1 Black and White Photograph, 1 Diagram.